Genzyme Corporation v. Zydus Pharmaceuticals (Usa)
Genzyme Corporation v. Zydus Pharmaceuticals (Usa)
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
GENZYME CORPORATION, SANOFI-AVENTIS U.S., LLC, Plaintiffs-Appellees
v.
ZYDUS PHARMACEUTICALS (USA) INC., Defendant-Appellant ______________________
2018-2362 ______________________
Appeal from the United States District Court for the District of Delaware in No. 1:16-cv-00540-KAJ, Circuit Judge Kent A. Jordan. ______________________
JUDGMENT ______________________
PAUL HENRY BERGHOFF, McDonnell, Boehnen, Hulbert & Berghoff, LLP, Chicago, IL, argued for plaintiffs-appel- lees. Also represented by ALISON JAMEEN BALDWIN, NATHANIEL PAUL CHONGSIRIWATANA, DANIEL F. GELWICKS, NICOLE E. GRIMM, JAMES LEE LOVSIN, JEREMY E. NOE, KURT WILLIAM ROHDE; JEFFREY B. BOVE, Ratner Prestia, Wilmington, DE.
CHAD A. LANDMON, Axinn Veltrop Harkrider, LLP, Hartford, CT, argued for defendant-appellant. Also repre- sented by DAVID KEELER LUDWIG, EDWARD M. MATHIAS; DAN-FENG MEI, New York, NY. ______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (NEWMAN, CHEN, and HUGHES, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
August 16, 2019 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Reference
- Status
- Unpublished